Corcept Therapeutics
- Active openings
- 20+
- US-based roles
- 0
- Remote-friendly
- 0
- Last updated
- 2026-09-16
What Corcept Therapeutics is hiring for
Open positions
20+ active- Senior Manager, Scientific Communication OperationsSep 16
- Associate Director, Medical WritingSep 16
- Senior Director, Legal & Compliance, OUS RegionsSep 10
- Director, Human ResourcesSep 10
- Senior Manager, Digital & Omnichannel Marketing (Customer Experience)Sep 10
About Corcept Therapeutics
Claim to unlockMission, culture, and benefits - visible once this page is claimed and verified.
Updates
Prevalence of Hypercortisolism in Individuals With Resistant Hypertension and Cardiovascular Disease
Prevalence of Endogenous Hypercortisolism in Individuals With Resistant Hypertension Stratified by Kidney Function: Results From the MOMENTUM Study
Efficacy and Safety of Relacorilant + Nab-paclitaxel in Patients Aged ≥65 Years With Platinum-resistant Ovarian Cancer (PROC) in the Phase 3 ROSELLA Study (GOG-3073, ENGOT-OV72, APGOT-Ov10)
Real-World Comparative Effectiveness of Nab-paclitaxel and Standard of Care Chemotherapies in Patients With Platinum-Resistant Ovarian Cancer (COMPASS 2.0)
Endogenous Hypercortisolism in Individuals With Resistant Hypertension and Difficult-to-Control Type 2 Diabetes: Results From Two Large, Prospective Studies
Characterization of Individuals With Resistant Hypertension and Post-Dexamethasone Suppression Test Cortisol 1.8 μg/dL: Results From the MOMENTUM Study